Approach
Derek finds the financial forecast of Mindzecor to be concerning. He then shows
projections that include three other types of drugs, what they've currently spent on R&D,
and what they would expect to spend on R&D once it's done. There is also the expected
profit for each drug. He clarifies how Memaretine is Mindzecor. - ✔️✔️Profitability vs.
R&D Expense
Bildenafil (Cosmetic)
Total R&D Expense (current + forecast): 8,800,000,000
R&D Expense (current): 5,910,000,000
Profit (forecast): 15,000,000,000
Proxymanifax (Erectile Dysfunction)
Total R&D Expense (current + forecast): 7,200,000,000
R&D Expense (current): 4,800,000,000
Profit (forecast): 2,100,000,000
Memaretine (Neurological Disease)
Total R&D Expense (current + forecast): 3,510,000,000
R&D Expense (current): 3,290,000,000
Profit (forecast): 3,450,000,000
Derocodine (Painkiller)
Total R&D Expense (current + forecast): 7,900,000,000
R&D Expense (current): 4,100,000,000
Profit (forecast): 8,700,000,000
Based on the given information, Derek suggests that they stop funding Mindzecor and
focus on more profitable projects.
Chloe, however, has concerns as there are thousands of individuals who die from
neurological diseases, something that Mindzecor can cure.
There are four types of ethical approaches that you can take: - ✔️✔️Ethical Egoism
(Individualistic)
The normative theory that they promotion of one's good is in accordance with morality.
In it's strong version, it is held that it is always moral to promote one's own good, and it
is never moral not to promote it.
Compulsory